Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.8 GBX | +2.08% | -2.24% | +18.93% |
10/04 | FTSE 100 Closes Up 0.3% as U.S. Uncertainty Boosts Appetite for U.K. Stocks | DJ |
10/04 | E-Therapeutics says company faces lack of interest as UK listing | AN |
Sales 2022 | 0.48 39.77 | Sales 2023 | 0.48 39.6 | Capitalization | 93.73M 7.81B |
---|---|---|---|---|---|
Net income 2022 | -8M -667M | Net income 2023 | -8M -667M | EV / Sales 2022 | 30,69,56,621 x |
Net cash position 2022 | 25.96M 2.16B | Net cash position 2023 | 31.39M 2.62B | EV / Sales 2023 | 13,12,28,741 x |
P/E ratio 2022 |
-20.3
x | P/E ratio 2023 |
-10.5
x | Employees | 34 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.56% |
1 day | +2.08% | ||
1 week | -2.24% | ||
Current month | -10.91% | ||
1 month | -12.11% | ||
3 months | -39.69% | ||
6 months | -6.44% | ||
Current year | +18.93% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 01/20/01 |
Director of Finance/CFO | - | - | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Jones
CHM | Chairman | 82 | 28/15/28 |
Director/Board Member | 68 | 11/20/11 | |
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 01/20/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 9.8 | +2.08% | 2,327,452 |
25/24/25 | 9.6 | +4.63% | 2,228,014 |
24/24/24 | 9.175 | +3.67% | 2,186,052 |
23/24/23 | 8.85 | -13.66% | 3,758,132 |
22/24/22 | 10.25 | +2.24% | 1,237,276 |
Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+18.93% | 71.33M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ETX Stock